2014 CME Symposia - Lunch Symposium C

Register for the CMHC today to sign up for these value-added CME/CE activities-at no additional cost!

Pre-registration for symposia will open at the end of August for CMHC registrants to make selections. There are no additional fees to attend. Symposia include meals or refreshments and seating is limited and on a first-come, first-serve basis.

CME Lunch Symposium C

Friday · 12:30 ? 2:00pm

Individualizing Therapy in Patients with Stable Ischemic Heart Disease:
Managing the Full Spectrum of Comorbidities and Cardiometabolic Risk Factors

Supported by an educational grant from Gilead Sciences, Inc.

Symposium Overview

Approximately 10 million individuals in the U.S. have angina, with 500,000 new cases being diagnosed each year. Cardiovascular risk reduction for patients with Stable Ischemic Heart Disease (SIHD) should focus on appropriate evaluation and diagnosis of symptoms to guide treatment and management of concomitant risk factors. This symposium will review the updated guidelines for the diagnostic and treatment of patients with SIHD, with a focus on select comorbidities, such as gender, heart failure, and diabetes. Faculty will also discuss appropriate risk-stratification and decision-making strategies to determine which patients should receive revascularization and which patients should be managed with medication.

Learning Objectives

  • Improve recognition, diagnosis and outcomes for individuals with SIHD by utilizing guideline-based diagnostic tools, risk stratification methods, and therapeutic approaches supported by current clinical data.
  • Appropriately select optimal guideline-based medical therapy and revascularization for patients with SIHD.
  • Personalize guideline-based treatment goals for patients with SIHD, based upon factors such as gender, heart failure, diabetes, and refractory angina.
  • Apply evidence-based strategies to personalize treatment for patients with SIHD, Type 2 Diabetes Mellitus (T2DM) and other cardiometabolic risk factors or comorbidities, that improve heart rate, blood pressure, and cardiometabolic profile.

Preliminary Agenda & Faculty

12:30 ? 12:35pm Welcome and Introductions Chairperson: JoAnne M. Foody, MD
12:35 ? 12:55pm Evidence-based Approaches and Clinical Practice Guidelines for the Diagnosis and Management of Patients with SIHD Presenter: Peter H. Stone, MD
12:55 ? 1:15pm Medication or Revascularization? Implications of Clinical Trial Data for Decision Making Presenter: Deepak L. Bhatt, MD, MPH
1:15 ? 1:35pm Personalized Management for Patients with SIHD & Type 2 Diabetes: Examining the Clinical Evidence Presenter: Suzanne V. Arnold, MD
1:35 ? 2:00pm Strategies to Optimize the Management of Patients with SIHD and Reduce Cardiometabolic Risk:
Case Study Presentations, Interactive Panel Discussion and Audience Q&A
Moderator: JoAnne M. Foody, MD
Discussants: Suzanne V. Arnold, MD; Deepak L. Bhatt, MD, MPH; Peter H. Stone, MD

Suzanne V. Arnold, MD, MHA

  • Clinical Scholar and Cardiologist
  • Saint Luke's Mid America Heart Institute
  • Research Assistant Professor
  • Department of Biomedica & Health Informatics
  • University of Missouri-Kansas City

Deepak L. Bhatt, MD, MPH

  • Professor of Medicine
  • Harvard Medical School
  • Executive Director
  • Interventional Cardiovascular Programs
  • Brigham and Women's Hospital Heart and Vascular Center
  • Boston, MA

JoAnne M. Foody, MD

  • Medical Director
  • Cardiovascular Wellness Program
  • Brigham and Women's Hospital
  • Associate Professor
  • Harvard Medical School

Peter H. Stone, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Co-Director, Samuel A. Levine Cardiac Unit
  • Director, Clinical Trials Center
  • Brigham and Women's Hospital

View Complete Accreditation Details and Program Overview: CMHC Accreditation